Mixed Tumor, Mesodermal: Clinical Trials

5 trials for Mixed Tumor, Mesodermal, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 active not recruiting, 1 terminated. 2 Phase 1, 2 Phase 2, 1 Not applicable.

By phase and status

PhaseTrialsStatus
Phase 12Completed 2
Phase 22Completed 1, Terminated 1
Not applicable1Active not recruiting 1

Follow Mixed Tumor, Mesodermal: new trials by email Literature Review of Mixed Tumor, Mesodermal trials Research Report on Mixed Tumor, Mesodermal

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
PET/CT and Lymph Node Mapping in Finding Lymph Node Metastasis in Patients With High-Risk Endometrial Cancer
Computed Tomography, Indocyanine Green Solution, Laboratory Biomarker Analysis - Endometrial Clear Cell Adenocarcinoma, Endometrial Mixed Adenocarcinoma
Not applicableActive not recruitingM.D. Anderson Cancer Center1012013-04-032026-10-08
Study of Oral PXD101 in Patients With Advanced Solid Tumors or Lymphoma
oral belinostat - Solid Tumor, Lymphoma
Phase 1CompletedValerio Therapeutics1212006-06-012015-07-08
Carboplatin and Paclitaxel in Elderly Women With Newly Diagnosed Ovarian, Peritoneal, or Fallopian Cancer
Paclitaxel, Carboplatin - Ovarian Cancer, Primary Peritoneal Carcinoma
Phase 2TerminatedDana-Farber Cancer Institute122006-04-012018-09-10
Study of PXD101 Alone and in Combination With 5-Fluorouracil (5-FU) in Patients With Advanced Solid Tumors
belinostat, 5-Fluorouracil (5-FU) - Tumor
Phase 1CompletedValerio Therapeutics352005-09-012015-07-08
Adjuvant Radiation Therapy With Ifosfamide in Patients With Mixed Mesodermal Tumors of the Uterus
Ifosfamide, Radiation Therapy, Cisplatin - Uterine Cancer
Phase 2CompletedMontefiore Medical Center302003-02-012019-01-23

Narrower conditions

Ovarian Neoplasms (3)  ·  Adenosarcoma (2)  ·  Breast Neoplasms (2)  ·  Carcinoma, Non-Small-Cell Lung (2)  ·  Carcinoma, Small Cell (2)  ·  Chondrosarcoma (2)  ·  Colorectal Neoplasms (2)  ·  Esophageal Neoplasms (2)  ·  Fibrosarcoma (2)  ·  Head and Neck Neoplasms (2)  ·  Hemangiosarcoma (2)  ·  Kidney Neoplasms (2)  ·  Leiomyosarcoma (2)  ·  Liposarcoma (2)

Broader conditions

Neoplasms by Histologic Type (5)  ·  Neoplasms, Complex and Mixed (5)  ·  Neoplasms, Connective and Soft Tissue (5)  ·  Female Urogenital Diseases (4)  ·  Female Urogenital Diseases and Pregnancy Complications (4)  ·  Genital Diseases (4)  ·  Genital Diseases, Female (4)  ·  Genital Neoplasms, Female (4)  ·  Neoplasms (4)  ·  Neoplasms by Site (4)  ·  Urogenital Diseases (4)  ·  Urogenital Neoplasms (4)  ·  Adnexal Diseases (3)  ·  Endocrine Gland Neoplasms (3)  ·  Endocrine System Diseases (3)

Interventions

belinostat (2)  ·  Carboplatin (1)  ·  Cisplatin (1)  ·  Fluorouracil (1)  ·  Ifosfamide (1)  ·  Indocyanine Green (1)  ·  Lymph Node Excision (1)  ·  Magnetic Resonance Spectroscopy (1)  ·  Paclitaxel (1)  ·  Radiotherapy (1)

Sponsors

Valerio Therapeutics (2)  ·  Dana-Farber Cancer Institute (1)  ·  M.D. Anderson Cancer Center (1)  ·  Montefiore Medical Center (1)

Countries

United States (5)  ·  Denmark (1)  ·  United Kingdom (1)

Top investigators

Mark H Einstein, M.D., M.S. (1)  ·  Pamela Soliman (1)  ·  Ursula Matulonis, MD (1)

Results publications

PMID 19058838, PMID 22055846

NIH funding

P50CA098258 (1)